Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04752826
Title BI-1808 as a Single Agent and With Pembrolizumab in Treatment of Advanced Malignancies(Keynote-D20)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioInvent International AB
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Rigshospitalet RECRUITING Copenhagen Denmark Details
Herlev Hospital RECRUITING Herlev 2730 Denmark Details
PRA Health Sciences - Hungary ACTIVE_NOT_RECRUITING Budapest 1077 Hungary Details
Magyar Honvédség-Egészségügyi Központ RECRUITING Budapest 1134 Hungary Details
Debreceni Egyetem Klinikai Központ RECRUITING Debrecen 4032 Hungary Details
Byudzhetnoye Uchrezhdeniye Zdravookhraneniya Omskoy Oblasti - Klinicheskiy Onkologicheskiy Dispanser TERMINATED Omsk 644013 Russian Federation Details
National Medical Research Center VA Almazov WITHDRAWN Saint Petersburg 197022 Russian Federation Details
N.N. Petrov National Medical Research Center of Oncology WITHDRAWN St Petersburg 197758 Russian Federation Details
University Hospitals of Leicester NHS Trust RECRUITING Leicester LE1 5WW United Kingdom Details
Guy's and Saint Thomas' NHS Foundation Trust RECRUITING London SE1 9RT United Kingdom Details
The Christie NHS Foundation Trust RECRUITING Manchester M20 4BX United Kingdom Details
Southampton General Hospital RECRUITING Southampton SO16 6YD United Kingdom Details
*Shaded cells indicate that there was no data available from for the field